中共党员，中国药科大学生物制药教研室副研究员，硕士研究生导师。2016年毕业于中国药科大学获博士学位。教育部学位论文评审专家，中国药学会会员，美国基因与细胞治疗学会会员。主要研究方向为1) 生物大分子药物成药性研究、2) 聚多肽平台的开发及应用。以上研究领域已主持国家自然科学基金、江苏省自然科学基金、中国博士后基金等项目5项，参与“重大新药创制”、国家自然科学基金等国家级项目13项。申请专利4项，已获授权3项；近五年以通讯作者或第一作者在JACS、Adv Funct Mater、Nano Lett、Brit J Pharmacol、J Control Release、J Med Chem、Cancer Lett等杂志发表SCI论文19篇，影响因子累计大于200分。

近五年发表的影响因子大于10分的代表性论文：

1.       Yue Ji#, Dingkang Liu#, Haichao Zhu, Lichen Bao, Ruilong Chang, Xiangdong Gao*, Jun Yin*. Unstructured Polypeptides as a Versatile Drug Delivery Technology. Acta Biomaterialia. 2023,164:74-93. 

2.       Yifang Yang#, Haichao Zhu#, Dingkang Liu, Hong Luo, Ruilong Chang, Yue Ji, Wenbing Yao*, Jun Yin*, Xiangdong Gao*. A Versatile Platform for the Tumor-Targeted Intracellular Delivery of Peptides, Proteins, and siRNA. Advanced Functional Materials. 2023, 2301011. https://doi.org/10.1002/adfm.202301011

3.       Dingkang Liu#, Lichen Bao#, Haichao Zhu, Yue Ji, Tian Jing, Xiangdong Gao*, Jun Yin*. Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy. Journal of Controlled Release. 2023; 354: 606-614.

4.        Dingkang Liu#, Ye Chen#, Qun Wang, Yue Ji, Lichen Bao, Wenbing Yao*, Xiangdong Gao*, Jun Yin*. Tailored protein-conjugated DNA nanoplatform for synergistic cancer therapy. Journal of Controlled Release. 2022, 346:250-259.

5.        Qun Wang, Yifan Yang, Dingkang Liu, Yue Ji, Xiangdong Gao*, Jun Yin*, Wenbing Yao*. Cytosolic Protein Delivery for Intracellular Antigen Targeting Using Supercharged Polypeptide Delivery Platform. Nano Letters, 2021,21,6022-6030.

6.        Jun Yin#, Qun Wang#, Shan Hou, Lichen Bao, Wenbing Yao*, Xiangdong Gao*. Potent Protein Delivery into Mammalian Cells via a Supercharged Polypeptide. Journal of the American Chemical Society, 2018, 140, 17234-17240.